Filter
8687
Filtered Results: 8687
Text search:
health
outcomes
Featured
Recommendations
698
New Publications
2153
Language
Document type
No document type
4945
Studies & Reports
1570
Guidelines
1053
Manuals
412
Strategic & Response Plan
289
Fact sheets
157
Training Material
135
Situation Updates
55
Resource Platforms
28
Infographics
16
Brochures
10
Online Courses
10
Dashboards/Maps
4
Videos
2
App
1
Countries / Regions
Global
383
India
361
Kenya
254
Ethiopia
189
South Africa
189
Nepal
163
Western and Central Europe
159
Sierra Leone
155
Uganda
153
Nigeria
144
Africa
132
Malawi
131
Liberia
126
Myanmar / Burma
123
Zambia
119
Bangladesh
113
Latin America and the Carribbean
111
Rwanda
110
Tanzania
108
Ghana
95
Ukraine
85
Syria
74
Namibia
70
Eastern Europe
68
Philippines
64
Indonesia
60
Russia
58
Congo, Democratic Republic of
57
Cambodia
55
Brazil
55
Lesotho
54
Zimbabwe
53
South–East Asia Region
49
Asia
48
Guinea
45
Senegal
42
South Sudan
41
Germany
40
Mozambique
38
West and Central Africa
37
East and Southern Africa
36
Haiti
35
Colombia
33
Eastern Europe and Central Asia
30
Botswana
29
Middle East and North Africa
29
Burkina Faso
27
Yemen
27
Cameroon
26
Pakistan
25
Afghanistan
22
USA
21
Western Pacific Region
20
Benin
19
Sudan
18
Venezuela
18
Lebanon
17
Eswatini/ Swaziland
17
Jordan
16
Somalia
15
Thailand
15
Argentina
14
Chile
13
Vietnam
13
Peru
12
Tajikistan
12
Central African Republic
11
Ecuador
11
Paraguay
11
Laos
11
Albania
10
North America
10
Mali
9
China
9
Bolivia
8
Moldova
8
Georgia
8
United Kingdom
8
Iraq
7
Turkey
7
Angola
7
Southern Africa
7
Spain
7
Egypt
6
Gambia
6
Madagascar
6
Palestine
6
Iran
6
Kyrgyzstan
6
Jamaica
6
Papua New Guinea
5
Sri Lanka
5
Estonia
5
Portugal
5
Guinea-Bissau
4
Côte d’Ivoire / Ivory Coast
4
North Macedonia
4
Burundi
4
Guatemala
4
Mexico
4
Bhutan
4
Canada
4
Kazakhstan
4
Saudi Arabia
3
Niger
3
Togo
3
Chad
3
Serbia
3
Honduras
3
El Salvador
3
Libya
3
Armenia
3
Timor Leste/ East Timor
3
Turkmenistan
3
Japan
3
Mauritius
3
Azerbaijan
3
Morocco
2
Ireland
2
Singapore
2
Hungary
2
Croatia
2
Nicaragua
2
Other region
2
Fiji
2
Qatar
2
Romania
2
Belarus
2
Malaysia
1
Mauritania
1
Dominican Republic
1
Switzerland
1
Greece
1
Solomon Islands
1
Poland
1
Italy
1
Djibouti
1
Congo-Brazzaville
1
Bulgaria
1
Lithuania
1
Australia
1
Uruguay
1
France
1
Maldives
1
Tunisia
1
Norway
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Barbados
1
Authors & Publishers
Publication Years
Category
Countries
3068
Clinical Guidelines
645
Public Health
546
Women & Child Health
460
Key Resources
368
Capacity Building
157
Pharmacy & Technologies
64
Toolboxes
Mental Health
805
HIV
713
COVID-19
658
TB
523
Disability
372
Planetary Health
353
Caregiver
268
NCDs
234
AMR
211
Rapid Response
210
Ebola
197
Conflict
189
NTDs
188
Global Health Education
161
Refugee
155
Pharmacy
121
Health Financing Toolbox
96
Natural Hazards
79
Zika
56
Cholera
44
Social Ethics
39
Polio
38
Specific Hazards
30
Typhoon
3
Health Financing
3
In the region, it is estimated that there are over 650 million persons with disabilities. However, without accurate, timely and disaggregated data, countries are unable to develop effective policies and programmes, monitor the wellbeing of persons with disabilities and evaluate the equity and impact...
Hypertension and COVID-19: Scientific report - 17 June 2021
The Lancet March 17, 2022DOI:https://doi.org/10.1016/S0140-6736(22)00525-6
ISN Public Affairs Kidney International Supplements (2020) 10, e19–e23
Panam Salud Publica. 2021;45:e22. https://doi.org/10.26633/RPSP.2021.22
Curr HIV/AIDS Rep. 2022; 19(1): 37–45.
Published online 2022 Jan 29. doi: 10.1007/s11904-021-00589-4.
COVID-19 has had an unprecedented impact on the cascade-of-care among PLWH in LAC. There is a need for
longitudinal studies that assess clinic implication of these pandemic interactions in LAC.
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
Analysis of microfilaria prevalence data from 430 communities
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
This regional action plan provides a broad framework for the regional level to assist governments in accelerating the implementation of existing international, regional and national commitments on ending FGM. Formulating the plan has provided an opportunity for the region to identify broad prioritie...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
The World Heart Federation (WHF) has been advocating globally for stronger
legislation and policy regarding cardiovascular disease (CVD) for many years. Now, as focus shifts from global to national progress, we call on members and colleagues to advocate for greater action on CVD in your local setti...
Global progress against cardiovascular disease (CVD) is flatlining.
Though rates of CVD deaths globally have fallen in the last three
decades, this trend has begun to stall and, without concerted
efforts, is at risk of reversing.
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
